Lm. Rich et Wf. Piering, URETERAL STENOSIS DUE TO RECURRENT WEGENERS GRANULOMATOSIS AFTER KIDNEY-TRANSPLANTATION, Journal of the American Society of Nephrology, 4(8), 1994, pp. 1516-1521
The Nephrology Division of the Department of Medicine at the Medical C
ollege of Wisconsin was initiated in 1962 as the Renal Section of the
predecessor Marquette University School of Medicine under the directio
n of Dr. Edward J. Lennon. Currently, the Nephrology Division has II f
aculty members based in the adjoining Froedtert Memorial Lutheran Hosp
ital/Milwaukee County Medical Complex (FMLH/MCMC) at the Milwaukee Reg
ional Medical Center Campus and at the Milwaukee VA Medical Center. Th
e current chairman, Dr, Jocob Lemann, Jr., has lead the division for o
ver 20 yr. The faculty share supervision of patient care and pursue re
search in renal tubular cell biology, physiology and toxic injury, exp
erimental glomerulonephritis, radiation nephritis, nephrolithiasis, an
d collaborative treatment trials in diabetic nephropothy and in perito
neal dialysis. During 1992, the Nephrology Division at the Medical Col
lege of Wisconsin provided direct care for 560 inpatients admitted to
the shared Nephrology/Transplantation Unit at FMLH, as well as 800 inp
atient consultations, more than 4,000 outpatient visits, and supervisi
on of 160 chronic hemodialysis patients and 50 patients maintained on
continuous ambulatory peritoneal dialysis and continuous cyclic perito
neal dialysis at FMLH/MCMC and VAMC. Additionally, assistance in the c
are of 100 patients receiving kidney grafts during 1992 was also provi
ded.More than 30 physicians have received clinical nephrology and rese
arch training since the inception of the program, with more than one t
hird of these subsequently undertaking careers in academic medicine. C
urrently, two trainees have just begun the program while two others in
their second year are participating in studies of experimental glomer
ulonephritis and in studies to improve the efficacy of peritoneal dial
ysis. Opportunities exist for trainees with special clinical or labora
tory research interests to remain in the program for a third/fourth ye
ar.